Login / Signup

Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51.

Vanessa BuffaFabian H KnaupTim HeymannMargherita SpringerMathias V SchmidtFelix Hausch
Published in: ACS pharmacology & translational science (2023)
The FK506-binding protein 51 (FKBP51) has emerged as an important regulator of the mammalian stress response and is involved in persistent pain states and metabolic pathways. The FK506 analog SAFit2 (short for selective antagonist of FKBP51 by induced fit) was the first potent and selective FKBP51 ligand with an acceptable pharmacokinetic profile. At present, SAFit2 represents the gold standard for FKBP51 pharmacology and has been extensively used in numerous biological studies. Here we review the current knowledge on SAFit2 as well as guidelines for its use.
Keyphrases
  • binding protein
  • chronic pain
  • healthcare
  • multidrug resistant
  • pain management
  • neuropathic pain
  • transcription factor
  • diabetic rats
  • spinal cord injury
  • oxidative stress
  • living cells
  • spinal cord
  • anti inflammatory